SMO Pharmatech Oncology Inc — Denver, Colorado

SMO Pharmatech Oncology Inc is a clinical research site located in Denver, Colorado, United States 80203.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

SMO Pharmatech Oncology Inc has participated in 1 clinical trials.

Therapeutic areas: Breast Cancer, Hormone Receptor Positive Tumor, Early-Stage Breast Carcinoma.

Sponsors: Eli Lilly and Company.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for SMO Pharmatech Oncology Inc?

SMO Pharmatech Oncology Inc has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has SMO Pharmatech Oncology Inc conducted?

SMO Pharmatech Oncology Inc has 1 clinical trials on record. Their work covers Breast Cancer, Hormone Receptor Positive Tumor, Early-Stage Breast Carcinoma.

Is SMO Pharmatech Oncology Inc accredited by Crixeo Health?

SMO Pharmatech Oncology Inc has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about SMO Pharmatech Oncology Inc?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.